Adenosine receptors expression is elevated in leukocytes of gestational diabetes mellitus (GDM) subjects - A preliminary study

Endokrynologia Polska

Volumn 63, Issue 2, 2012, Pages 110-114

  Zieleniak, Andrzej ^a   Cypryk, Katarzyna ^a,b   Wozniak, Lucyna Alicja ^a   Bieńkiewicz, Małgorzata ^a   Wójcik, Marzena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Adenosine receptors; GDM; Gene expression; Gestational diabetes mellitus

Indexed keywords

ADENOSINE RECEPTOR; GLUCOSE;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LEUKOCYTES; PREGNANCY; RECEPTORS, PURINERGIC P1; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84861152738     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fredholm BB, Ijzeman AP, Jacobson KA et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552. (Pubitemid 33136237)
2. Fredholm BB, Arslan G, Halldner L et al. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 364-374.
3. Baraldi PG, Tabrizi MA, Gessi S, Borea PA. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 2008; 108: 238-263. (Pubitemid 351176408)
4. Yasuda N, Inoue T, Horizoe T et al. Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Eur J Pharmacol 2003; 459: 159-166. (Pubitemid 36078316)
5. Hasko G, Csoka B, Nemeth ZH et al. A2B adenosine receptors in immunity and inflammation. Trends Immunol 2009; 30: 263-270.
6. Gessi S, Merighi S, Varani K et al. The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 2008; 117: 123-140. (Pubitemid 350192673)
7. Simola N, Morelli M, Pinna A. Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions. Curr Pharm Des 2008; 14: 1475-1489. (Pubitemid 351997813)
8. Dhalla AK, Chisholm JW, Reaven GM et al. A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 2009; 193: 271-295.
9. Lin Z, Yin P, Reierstad S et al. Adenosine A1 receptor, a target and regulator of estrogen receptor alpha action, mediates the proliferative effects of estradiol in breast cancer. Oncogene 2010; 29: 1114-1122.
10. Wojcik M, Zieleniak A, Wozniak LA. New Insight Into A1 Adenosine Receptors in Diabetes Treatment. Current Pharmaceutical Design 2010; 38: 4237-4242.
11. Schwabe U, Schonhofer PS, Ebert R. Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3′, 5′- monophosphate, lipolysis, and glucose oxidation in isolated fat cells. Eur J Biochem 1974; 46: 537-545.
12. Dong Q, Ginsberg HN, Erlanger BF. Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity related insulin resistance. Diabetes Obes Metab 2001; 3: 360-366. (Pubitemid 33072216)
13. Dhalla AK, Chisholm JW, Reaven GM et al. A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 2009; 193: 271-295.
14. Elzein E, Zablocki J. A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opin Emerg Drugs 2008; 17: 1901-1910.
15. Grden M, Podgorska M, Szutowicz A, Pawelczyk T. Diabetes induced alterations of adenosine receptors expression level in rat liver. Exp Mol Pathol 2007; 83: 392-398. (Pubitemid 350087017)
16. Sakowicz-Burkiewicz M, Kocbuch K, Grden M et al. Protein kinase C mediated high glucose effect on adenosine receptors expression in rat B lymphocytes. J Physiol Pharmacol 2009; 60: 145-53.
17. Sakowicz-Burkiewicz M, Kocbuch K, Grden M et al. Regulation of adenosine receptors expression in rat B lymphocytes by insulin. J Cell Biochem 2010; 109: 396-405.
18. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491. (Pubitemid 40322217)
19. Lewandowski K, Nadel I, Lewinski A et al. Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol 2010; 81: 907-912.
20. Cypryk K, Vilsbøll T, Nadel I et al. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol 2007; 23: 58-62.
21. Dudzik D, Skotnicki M, Zarzycki W et al. N-acetyl-β-D-hexosaminidase in gestational diabetes mellitus - a preliminary study. Sci 2011; 56: 44-47.
22. Xiang AH, Peters RK, Trigo E et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 1999; 48: 848-854. (Pubitemid 29153086)
23. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491. (Pubitemid 40322217)
24. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of WHO/IDF consultation. World Health Organization and International Diabetes Federation. WHO Document Production Services, Geneva, 2006.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29 (Suppl 1): S43-S48.
26. Sakowicz-Burkiewicz M, Kocbuch K, Grden M et al. Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes. Immunology 2006; 118: 402-412.
27. Grdeń M, Podgórska M, Szutowicz A, Pawełczyk T. Altered expression of adenosine receptors in heart of diabetic rat. J Physiol Pharmacol 2005; 56: 587-597. (Pubitemid 43127555)
28. Harada H, Asano O, Hoshino Y et al. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: Their synthesis and structure- activity relationships toward hepatic glucose production induced via agonism of the A2B receptor. J Med Chem 2001; 44: 170-179. (Pubitemid 32096661)
29. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-39. (Pubitemid 38032805)
30. Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 5627-5633. (Pubitemid 39518451)